Predilife (ALPRE.PA) Stock Highlights

3.64 | -1.62%

2024-12-21 07:37:25

Predilife SA develops solutions of predictive medicine combining proven medical techniques (genetic tests, medical imaging) and mathematical models using a large number of statistical data that could allow each individual to define his risk profile for the occurrence of a large number of serious diseases. The company markets its Mammorisk personalized breast cancer screening solution in Europe and the United States.

Statistics

Range Today

3.5 3.7

Volume Today 1.2K

Range 1 Year

3.32 24

Volume 1 Year 409.79K

Range 3 Year

3.32 24

Volume 3 Year 720.85K

Range 10 Year

3.32 24

Volume 10 Year 1.49M

Highlights

Market Capitalization 15.09M (micro)

Floating Shares 996.69K

Current Price 3.64

Price To Earnings -3.5

Earnings Per Share -1.2

Payout Ratio 0%

Performance

Latest -1.62%

1 Month -12.92%

3 Months -25.41%

6 Months -35%

1 Year -38.82%

3 Years -50.14%

5 Years -54.78%

10 Years -61.07%

Benchmarks

Market Capitalization

0 / 58

Gross Profits

0 / 52

Total Revenue

0 / 57

Total Rank

0 / 58

Free Cashflow

0 / 56

Performance 5 years

0 / 58

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.